Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MICROLET®NEXT 2 Lancing Device

K-Number: K250813 · 2025-05-14

Decision Date2025-05-14
Product CodeQRL
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MICROLET®NEXT 2 Lancing Device is a medical device manufactured by Ascensia Diabetes Care U.S., Inc.. It received FDA 510(k) clearance on 2025-05-14 under approval number K250813. The device is classified under product code QRL. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MICROLET®NEXT 2 Lancing Device?

MICROLET®NEXT 2 Lancing Device is a medical device that received FDA 510(k) clearance on 2025-05-14. It is manufactured by Ascensia Diabetes Care U.S., Inc.. The 510(k) number is K250813.

When was MICROLET®NEXT 2 Lancing Device approved by the FDA?

MICROLET®NEXT 2 Lancing Device received FDA 510(k) clearance on 2025-05-14, under approval number K250813.

What company makes MICROLET®NEXT 2 Lancing Device?

MICROLET®NEXT 2 Lancing Device is manufactured by Ascensia Diabetes Care U.S., Inc..

What is the FDA product code for MICROLET®NEXT 2 Lancing Device?

The FDA product code for MICROLET®NEXT 2 Lancing Device is QRL.

Other Devices by Ascensia Diabetes Care U.S., Inc.

View all 7 devices →

Related Devices (Code: QRL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.